Eli Lilly and Company (BVMF:LILY34)
131.57
-1.03 (-0.78%)
Last updated: Aug 28, 2025, 2:02 PM GMT-3
Eli Lilly and Company Market Cap
Eli Lilly and Company has a market cap or net worth of 3.56 trillion as of August 28, 2025. Its market cap has decreased by -20.70% in one year.
Market Cap
3.56T
Enterprise Value
3.75T
Revenue
290.19B
Ranking
n/a
PE Ratio
47.31
Stock Price
131.57
Market Cap Chart
Since July 9, 1970, Eli Lilly and Company's market cap has increased from 3.09B to 3.56T, an increase of 115,010.84%. That is a compound annual growth rate of 13.63%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
Aug 28, 2025 | 3,557.64B | -17.25% |
Dec 31, 2024 | 4,299.33B | 69.02% |
Dec 29, 2023 | 2,543.69B | 38.42% |
Dec 30, 2022 | 1,837.69B | 31.71% |
Dec 31, 2021 | 1,395.26B | 75.52% |
Dec 31, 2020 | 794.91B | 56.71% |
Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
Rede D'Or São Luiz | 82.86B |
Raia Drogasil | 31.02B |
Hypera | 14.92B |
Fleury | 7.73B |
Odontoprev | 7.10B |
Empreendimentos Pague Menos | 2.26B |
Blau Farmacêutica | 2.22B |
Oncoclínicas do Brasil Serviços Médicos | 1.90B |